Table 1 Clinical-pathological characteristics of enrolled BC patients
Clinicopathological Parameter (N = 45) | (N = 45) |
|---|---|
Median Age (in years) | 51 |
Tumor stage | |
T1 | 3 (7%) |
T2 | 23 (51%) |
T3 | 7 (15%) |
T4 | 12 (27%) |
Node status | |
N0 | 17 (38%) |
N+ | 28 (62%) |
Hormone receptor (HR) Status | |
HR+ | 25 (55%) |
HR- | 20 (45%) |
Her2 Status | |
Her2 + | 21 (47%) |
Her2 - | 24 (53%) |
Molecular type | |
HR+/HER2- | 14 (31%) |
HR+/HER2+ | 11 (25%) |
HR-/HER2+ | 10 (22%) |
HR-/HER2- | 10 (22%) |
Survival status | |
Live | 39 (87%) |
Dead | 6 (13%) |